Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry

A. Jochems; E. Bastiaannet; M.J.B. Aarts; A.C.J. van Akkooi; F.W.P.J. van den Berkmortel; M.J. Boers-Sonderen; A.J.M. van den Eertwegh; N.G. de Glas; J.W.B. de Groot; J.B.A.G. Haanen; G.A.P. Hospers; J.J.M. van der Hoeven; D. Piersma; R.S. van Rijn; K.P.M. Suijkerbuijk; A.J. ten Tije; A.A.M. van der Veldt; G. Vreugdenhil; M.C.T. van Zeijl; E. Kapiteijn; M.W.J.M. Wouters

doi:10.1016/j.jgo.2021.04.006

Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry

A. Jochems^*, E. Bastiaannet, M.J.B. Aarts, A.C.J. van Akkooi, F.W.P.J. van den Berkmortel, M.J. Boers-Sonderen, A.J.M. van den Eertwegh, N.G. de Glas, J.W.B. de Groot, J.B.A.G. Haanen, G.A.P. Hospers, J.J.M. van der Hoeven, D. Piersma, R.S. van Rijn, K.P.M. Suijkerbuijk, A.J. ten Tije, A.A.M. van der Veldt, G. Vreugdenhil, M.C.T. van Zeijl, E. KapiteijnM.W.J.M. Wouters

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1031-1038
Number of pages	8
Journal	Journal of Geriatric Oncology
Volume	12
Issue number	7
DOIs	https://doi.org/10.1016/j.jgo.2021.04.006
Publication status	Published - 1 Sep 2021

Keywords

Metastatic melanoma
Older patients
Targeted therapy
Immune checkpoint inhibitors
Safety
Outcome
IMMUNE CHECKPOINT INHIBITORS
STAGE-III
DOUBLE-BLIND
IPILIMUMAB
IMMUNOTHERAPY
DABRAFENIB
NIVOLUMAB
AGE
MULTICENTER
VEMURAFENIB

Access to Document

10.1016/j.jgo.2021.04.006Licence: CC BY

Cite this

Jochems, A., Bastiaannet, E., Aarts, M. J. B., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., de Glas, N. G., de Groot, J. W. B., Haanen, J. B. A. G., Hospers, G. A. P., van der Hoeven, J. J. M., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., van Zeijl, M. C. T., ... Wouters, M. W. J. M. (2021). Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry. Journal of Geriatric Oncology, 12(7), 1031-1038. https://doi.org/10.1016/j.jgo.2021.04.006

Jochems, A. ; Bastiaannet, E. ; Aarts, M.J.B. ; van Akkooi, A.C.J. ; van den Berkmortel, F.W.P.J. ; Boers-Sonderen, M.J. ; van den Eertwegh, A.J.M. ; de Glas, N.G. ; de Groot, J.W.B. ; Haanen, J.B.A.G. ; Hospers, G.A.P. ; van der Hoeven, J.J.M. ; Piersma, D. ; van Rijn, R.S. ; Suijkerbuijk, K.P.M. ; ten Tije, A.J. ; van der Veldt, A.A.M. ; Vreugdenhil, G. ; van Zeijl, M.C.T. ; Kapiteijn, E. ; Wouters, M.W.J.M. / Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry. In: Journal of Geriatric Oncology. 2021 ; Vol. 12, No. 7. pp. 1031-1038.

@article{cfd0c26857aa48869500888a83898380,

title = "Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry",

keywords = "Metastatic melanoma, Older patients, Targeted therapy, Immune checkpoint inhibitors, Safety, Outcome, IMMUNE CHECKPOINT INHIBITORS, STAGE-III, DOUBLE-BLIND, IPILIMUMAB, IMMUNOTHERAPY, DABRAFENIB, NIVOLUMAB, AGE, MULTICENTER, VEMURAFENIB",

author = "A. Jochems and E. Bastiaannet and M.J.B. Aarts and {van Akkooi}, A.C.J. and {van den Berkmortel}, F.W.P.J. and M.J. Boers-Sonderen and {van den Eertwegh}, A.J.M. and {de Glas}, N.G. and {de Groot}, J.W.B. and J.B.A.G. Haanen and G.A.P. Hospers and {van der Hoeven}, J.J.M. and D. Piersma and {van Rijn}, R.S. and K.P.M. Suijkerbuijk and {ten Tije}, A.J. and {van der Veldt}, A.A.M. and G. Vreugdenhil and {van Zeijl}, M.C.T. and E. Kapiteijn and M.W.J.M. Wouters",

year = "2021",

month = sep,

day = "1",

doi = "10.1016/j.jgo.2021.04.006",

language = "English",

volume = "12",

pages = "1031--1038",

journal = "Journal of Geriatric Oncology",

issn = "1879-4068",

publisher = "Elsevier",

number = "7",

}

Jochems, A, Bastiaannet, E, Aarts, MJB, van Akkooi, ACJ, van den Berkmortel, FWPJ, Boers-Sonderen, MJ, van den Eertwegh, AJM, de Glas, NG, de Groot, JWB, Haanen, JBAG, Hospers, GAP, van der Hoeven, JJM, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, van der Veldt, AAM, Vreugdenhil, G, van Zeijl, MCT, Kapiteijn, E & Wouters, MWJM 2021, 'Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry', Journal of Geriatric Oncology, vol. 12, no. 7, pp. 1031-1038. https://doi.org/10.1016/j.jgo.2021.04.006

Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry. / Jochems, A.; Bastiaannet, E.; Aarts, M.J.B.; van Akkooi, A.C.J.; van den Berkmortel, F.W.P.J.; Boers-Sonderen, M.J.; van den Eertwegh, A.J.M.; de Glas, N.G.; de Groot, J.W.B.; Haanen, J.B.A.G.; Hospers, G.A.P.; van der Hoeven, J.J.M.; Piersma, D.; van Rijn, R.S.; Suijkerbuijk, K.P.M.; ten Tije, A.J.; van der Veldt, A.A.M.; Vreugdenhil, G.; van Zeijl, M.C.T.; Kapiteijn, E.; Wouters, M.W.J.M.

In: Journal of Geriatric Oncology, Vol. 12, No. 7, 01.09.2021, p. 1031-1038.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry

AU - Jochems, A.

AU - Bastiaannet, E.

AU - Aarts, M.J.B.

AU - van Akkooi, A.C.J.

AU - van den Berkmortel, F.W.P.J.

AU - Boers-Sonderen, M.J.

AU - van den Eertwegh, A.J.M.

AU - de Glas, N.G.

AU - de Groot, J.W.B.

AU - Haanen, J.B.A.G.

AU - Hospers, G.A.P.

AU - van der Hoeven, J.J.M.

AU - Piersma, D.

AU - van Rijn, R.S.

AU - Suijkerbuijk, K.P.M.

AU - ten Tije, A.J.

AU - van der Veldt, A.A.M.

AU - Vreugdenhil, G.

AU - van Zeijl, M.C.T.

AU - Kapiteijn, E.

AU - Wouters, M.W.J.M.

PY - 2021/9/1

Y1 - 2021/9/1

KW - Metastatic melanoma

KW - Older patients

KW - Targeted therapy

KW - Immune checkpoint inhibitors

KW - Safety

KW - Outcome

KW - IMMUNE CHECKPOINT INHIBITORS

KW - STAGE-III

KW - DOUBLE-BLIND

KW - IPILIMUMAB

KW - IMMUNOTHERAPY

KW - DABRAFENIB

KW - NIVOLUMAB

KW - AGE

KW - MULTICENTER

KW - VEMURAFENIB

U2 - 10.1016/j.jgo.2021.04.006

DO - 10.1016/j.jgo.2021.04.006

M3 - Article

C2 - 34020909

VL - 12

SP - 1031

EP - 1038

JO - Journal of Geriatric Oncology

JF - Journal of Geriatric Oncology

SN - 1879-4068

IS - 7

ER -